Ophthotech

Ophthotech (now Iveric) hits eye drug goals as shares jump for tiny biotech
Fierce Biotech
Mon, 10/28/19 - 10:36 am
Iveric Bio
Ophthotech
Zimura
gene therapies
dry age-related macular degeneration
Ophthotech becomes Iveric in pivot to gene therapies
Fierce Biotech
Tue, 04/16/19 - 10:57 am
Ophthotech
Iveric Bio
gene therapy
Ophthotech completes clean sweep of phase 3 trial flops
Fierce Biotech
Mon, 08/14/17 - 10:06 am
Ophthotech
clinical trials
Fovista
wet age-related macular degeneration
Novartis hits pause on Fovista agreement
BioPharma Dive
Mon, 07/10/17 - 11:21 pm
Novartis
Fovista
Ophthotech
wet age-related macular degeneration
These five biotech CEOs earned big bucks even as their companies tanked
Stat
Fri, 05/5/17 - 10:33 am
biotech
executive pay
Seres Therapeutics
Pacira
Ophthotech
Cempra
Endo International
Ophthotech cuts to hit around 80% of staffers after phase 3 failures
Fierce Biotech
Wed, 01/18/17 - 10:03 am
layoffs
Ophthotech
Fovista
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space
Endpoints
Fri, 12/16/16 - 09:50 am
Ophthotech
layoffs
Fovista
Regeneron
What Fovista's Fail Means For OHR Pharma
Yahoo/Benzinga
Wed, 12/14/16 - 09:17 am
Fovista
Ohr Pharmaceutical
Ophthotech
Regeneron
rinucumab
squalamine
wet age-related macular degeneration
Ophthotech Plunges on Eye Drug Study Failure
TheStreet.com
Mon, 12/12/16 - 09:17 am
Ophthotech
clinical trials
Fovista
Lucentis
wet age-related macular degeneration
The Street Is Getting The Ophthotech Story All Wrong
Yahoo/Benzinga
Sun, 10/30/16 - 11:18 am
Ophthotech
Fovista
Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista
Yahoo/Benzinga
Tue, 10/4/16 - 10:17 am
Regeneron
Eylea
clinical trials
Ophthotech
Fovista
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
These 3 Biotechs Have Automatic Demand
Motley Fool
Mon, 07/25/16 - 09:55 am
biotech
Acadia
Portola Pharmaceuticals
Ophthotech
3 Biotechs Expecting Market-Moving Trial Results Soon
Motley Fool
Mon, 06/6/16 - 11:07 am
biotech
Ophthotech
Achillion
Kite Pharma
odalasvir
JNJ
Fovista
KTE-C19
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
Ophthotech reports 4Q loss
Yahoo/AP
Wed, 02/24/16 - 10:53 am
Ophthotech
earnings
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
3 Small-Cap Biotech Stocks With Big News Coming in 2016
Motley Fool
Sat, 12/12/15 - 02:05 pm
biotech
Ophthotech
Fovista
andexanet alfa
Portola Pharmaceuticals
ACH-3102
Achillion
Roche joins Novartis' billion-dollar bet on Ophthotech's eye drug
Fierce Biotech
Tue, 11/17/15 - 05:53 pm
Roche
Novartis
Ophthotech
pegpleranib

Pages